Rapidly rising global caseload of cancer, increasing use of brachytherapy in cancer management, and technological advancements in afterloading techniques are key factors expected to drive market growth.
Rapidly rising global caseload of cancer, increasing use of brachytherapy in cancer management, and technological advancements in afterloading techniques are key factors expected to drive market growth
The global brachytherapy market size is expected to reach 611.22 million in 2028 and register a CAGR of 4.7% during the forecast period, according to the latest report by Reports and Data. Increasing use of brachytherapy as a monotherapy or in conjunction with other treatment approaches for cancer management, rising global prevalence of cancer globally, use of brachytherapy to reduce potential recurrence of gynecologic cancers, and ability of brachytherapy to alleviate tumor symptoms and minimize radiation side effects are some key factors expected to drive market revenue growth over the forecast period. In addition, palliative brachytherapy can drastically reduce tumor symptoms such as dyspnea and cough and provides symptomatic relief in 50-99% of cancer patients and this has further boosted its adoption in cancer management strategies and is expected to continue to drive market growth.
Brachytherapy is a radiotherapy technique in which radioactive devices are implanted near tumor sites to safely delivery high doses of radiation to eliminate and shrink malignant tumors while simultaneously preventing damage to surrounding tissues. Since its development, brachytherapy has revolutionized the treatment approaches for breast, cervical, and prostate cancer. Brachytherapy is also a viable therapeutic option for occult early-stage lung cancer where surgery cannot be performed due to certain reasons. Major treatment sites for brachytherapy include cancers of uterine cervix, prostate, endometrium, eye, and head and neck. Commonly used techniques for brachytherapy include interstitial brachytherapy, intracavity brachytherapy, and episcleral brachytherapy. Over the recent past, brachytherapy has undergone remarkable technological advancement which has led to expansion of its potential application to a variety of clinical indications. Increasing investment to accelerate research and development activities in radiology is also expected to further contribute to revenue growth of the market.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/2640
However, long-term adverse effects associated with brachytherapy such as erectile dysfunction, bladder inflammation, leakage of urine, and nausea and fatigue can limit preference for brachytherapy for treatment of cancer. In addition, increasing concerns regarding radiation leakage in off-target sites can also potentially hamper use of brachytherapy and can potentially restrain market revenue growth to a certain extent over the forecast period.
Some Key Highlights From the Report:
- High-dose rate brachytherapy is widely used in treatment of prostate cancer, breast cancer, and skin cancer, among others owing to excellent ability to deliver high dose radiation directly to target tissue without causing radiation exposure to surrounding tissue. High dose rate brachytherapy is performed as an outpatient procedure and is cost-effective, convenient, and does not require hospital admission and these key factors are expected to contribute to revenue growth of this segment.
- Brachytherapy applicators segment is expected to register significant revenue growth over the forecast period owing to increasing availability of wide range of applicators that are designed to deliver precise doses of radiation and increasing use of applicators to guide radiation dose administration during treatment of gynecological cancers.
- Prostate cancer segment is expected to account for a significantly large revenue share over the forecast period attributable to high prevalence of prostate cancer worldwide, increasing use of HDR-BT to treat high-risk and non-metastatic prostate cancer, and growing awareness regarding benefits of brachytherapy in treatment of prostate cancer.
- Hospital segment revenue is expected to expand significantly attributable to availability advanced and high-end radiology equipment, presence of skilled radiologists, development of robust cancer care hospitals, increased access to state-of-the-art medical facilities, and implementation of favorable reimbursement policies.
- Asia Pacific is expected to register a steady revenue CAGR over the forecast period attributable to increasing prevalence of cancer in APAC countries such as India and China, rising investment to accelerate development of better healthcare facilities, growing preference for brachytherapy due to rising awareness regarding benefits of early treatment of cancer, and accessibility to advanced and next-gen cancer treatments.
- Major companies in the market report include Varian Medical Systems, Becton, Dickinson & Company, Elekta AB, Boston Scientific Corporation, CR Bard Inc., GE Healthcare, Carl Zeiss Meditec AG, Argon Medical Devices Inc., and Panacea Medical Technologies.
- In October 2021, Edinburgh Cancer Center announced that it would be offering high dose rate brachytherapy for treatment of aggressive prostate cancer. It is the first cancer care center in Scotland to offer HDR-BT for treating prostate cancer.
To know more about the report @ https://www.reportsanddata.com/report-detail/brachytherapy-market
For the purpose of this report, Reports and Data has segmented the brachytherapy market based on type, products, application, end use, and region:
Type Outlook (Revenue, USD Million; 2018-2028)
- High Dose Rate (HDR) Brachytherapy
- Low Dose Rate (LDR) Brachytherapy
Products Outlook (Revenue, USD Million; 2018-2028)
- Brachytherapy After Loader
- Brachytherapy Applicators
- Intraluminal Applicators
- Interstitial Applicators
- Intraoperative and Surface Applicators
- Brachytherapy Software
Application Outlook (Revenue, USD Million; 2018-2028)
- Prostate Cancer
- Gynecological Cancer
- Cervical Cancer
- Endometrial Cancer
- Vaginal Cancer
- Breast Cancer
- Other Cancers
End-Use Outlook (Revenue, USD Million; 2018-2028)
- Hospitals
- Oncology Treatment Centers
- Others
Buy Premium Research Report @ https://www.reportsanddata.com/checkout-form/2640
Regional Outlook (Revenue, USD Million; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/2640
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Healthcare Supply Chain Management Market By Product (Software, Hardware, Services), By Mode of Delivery (Cloud-Based, On-Premise), By End Use (Healthcare Manufacturers, Healthcare Providers, Distributors, Logistics), And By Region Forecasts to 2028
Cell Signaling Market By Product Type (Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling, and Others), By Product (Consumables and Instruments), By Application (Research and Medical), By Pathway (Akt, AMPK, ErbB/HER, Hedgehog, JAK/SAT, NF-eB, Notch, and Others) By Technology (Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry, ELISA, Mass Spectrometry, and Other) and By Region Forecast to 2028
Interventional Neurology Device Market , By Product (Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems, Support Devices, Neurothrombectomy Devices), By Disease Pathology (Ischemic Strokes, Cerebral Aneurysm, Carotid Artery Stenosis, Arteriovenous Malformations & Fistulas), By End, By Region, Forecast to 2028
Life Sciences Software Market , By Product Type (Cloud-based and On Premise), By End Use (Healthcare & Pharmaceuticals, Biotechnology, and Others), and By Region Forecast to 2028
Cholesterol Meter Market By Type (Single Index Detection, Multi-indicator Detection), By Test Type (Total Cholesterol, High-density Lipoprotein (HDL) Cholesterol, Low-density Lipoprotein (LDL) Cholesterol, Triglycerides, Others), By Application (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Diagnostic Centers, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region Forecast to 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370